Nature MedicineNEWS
Nature MedicineNEWS
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04716-9 This work developed and validated a computational pathology biomarker—the TROP2 normalized membrane ratio—that…
Read at original source ↗
Comments
No comments yet. Be the first to contribute.
✎ Write a comment